Kihealth Diabetes Risk Test

Our novel test, developed at Yale University, is the first early detection method that examines beta cell turnover, providing an initial insight into your risk of developing diabetes. By combining this innovative biomarker with a c-peptide test (to measure beta cell function), a Insulin test, and HbA1C test, we offer the most comprehensive diabetes risk assessment available.

Detecting diabetes early provides numerous advantages, such as the opportunity for earlier intervention and potentially mitigating or reducing the severity of the disease.